Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1324-1330

  Ramakrishnan, S ^a   Olson, T A ^a   Bautch, V L ^b   Mohanraj, D ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CHORIOALLANTOIS; CONJUGATE; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; RECEPTOR BINDING; VASCULAR ENDOTHELIUM;

ANIMALS; CELL DIVISION; CELLS, CULTURED; DIPHTHERIA TOXIN; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEMANGIOMA; HUMANS; IMMUNOTOXINS; LYMPHOKINES; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OVARIAN NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR CELLS, CULTURED; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029915612     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Folkman, J. What is the evidence that tumors are angiogenesis-dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
2. Weinstat-Saslow, D , and Steeg, P. S. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J., 8: 401-407, 1994.
3. Liotta, L. A., Steep, P S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of negative and positive regulation. Cell, 64: 327-336, 1991.
4. Fidler, I J., and Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994
5. Leek, R. D., Harris, A. L., and Lewis, C. E. Cytokine networks in solid human tumors. regulation of angiogenesis. J. Leukocyte Biol., 56: 423-435, 1994.
6. Tischer, E., Mitchell, R., Hartman, T., Silva, M., and Gospodarowicz, D. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem, 266: 11947-11954, 1991.
7. Shibuya, M , Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fms family. Oncogene, 5. 519-524, 1990
8. Devries, C , Escobedo, J A , Ueno, H., Houck, K., Ferrara, N., and Williams, L T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC), 255: 989-991, 1992.
9. ++ and von Willebrand factor release in human endothelial cells. Am. J Pathol., 138: 213-221, 1991.
10. Senger, D R., Van De Water, L , Brown, L. F., Nagy, J. A , Yeo, K. T., Yeo, T-K., Berse, B , Jackman, R. W., Dvorak, A M., and Dvorak, H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 303-324, 1993.
11. Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., and Leung, D. W. The vascular endothelial growth factor family of polypeptides. J. Cell Biochem., 47: 211-218, 1991.
12. Dvorak, H. F., Nagy, J. A., Berse, B., Brown, L. F., Yeo, K. T , Yeo, T. K., Dvorak, A. M., van de Water, L., Sioussat, T. M., and Senger, D. R. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation Ann. NY Acad. Sci , 667: 101-111, 1992.
13. Nagy, J A., Morgan, E S., Herzberg, K T., Manseau, E. J , Dvorak, A. M., and Dvorak, H. F. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining Cancer Res., 55: 376-385, 1995.
14. Auerbach, W., and Auerbach, R. Angiogenesis inhibition a review. Pharmcol & Ther , 63: 265-311, 1994.
15. Bicknell, R., and Harris, A. L. Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis Semin Cancer Biol , 3: 399-407, 1992.
16. Burrows, F. J , and Thorpe, P. E. Vascular targeting: a new approach to the therapy of solid tumors. Pharmacol. & Ther., 64: 155-174, 1994.
17. Ingber, D., Fujita, T , Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature (Lond ), 48: 555-557, 1990.
18. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
19. Thorpe, P E., Derbyshire, E. J , Andrade, S. P., Press, N., Knowles, P. P., King, S., Watson, G. J., Yang, Y-C., and Rao-Bette, M. Heparin-steroid conjugates: new angiogenesis inhibitors with antitumor activity in mice. Cancer Res., 53: 3000-3007, 1993.
20. Burrows, F. J., and Thorpe, P. E. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc. Natl. Acad. Sci. USA, 90: 8996-9000, 1993
21. Dubois, N. A., Kolpack, L. C., Wang, R., Azizkhan, R. G., and Bautch, V. L. Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas. Exp. Cell Res., 196: 302, 1991.
22. Li, B-Y., and Ramakrishnan, S. Recombinant hybrid toxin with dual enzymatic activities. Potential use in preparing highly effective immunotoxins. J. Biol. Chem., 269: 2652-2658, 1994.
23. Mohanraj, D., Fryxell, D , and Ramakrishnan, S. A novel method to purify immunotoxins from free antibody using modified recombinant toxin. J. Immunol. Methods, 182: 165-175, 1995.
24. Mohanraj, D., Olson, T., and Ramakrishnan, S. Expression of biologically active human vascular endothelial growth factor in yeast. Growth Factors, 12: 17-27, 1995.
25. Mohanraj, D., Olson, T., and Ramakrishnan, S. A novel method to purify recombinant vascular endothelial growth factor (VEGFI 21) expressed in yeast. Biochem. Biophys. Res. Commun., 215: 750-756, 1995.
26. Gitay-Goren, H., Soker, S., Vlodavsky, I. and Neufeld, G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem., 267: 6093-6098, 1992.
27. Olson, T. A. Mohanraj, D., Carson, L. F., and Ramakrishnan, S. Vascular permeability factor expression in normal and neoplastic human ovaries. Cancer Res. 54: 276-280, 1994.
28. Brown, L. F., Berse, B , Jackman, R. W., Tongnazzi, K , Manseau, E J., Senger, D. R , and Dvorak, H F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract Cancer Res., 53: 4727-4735, 1993.
29. Jakob, W., Jentzsch, K. D., Mauersberger, B., and Heder, G. The chick embryo chorioallantoic membrane as a bioassay for angiogenic factor: reaction induced by carrier materials. Exp. Pathol., 15: 241-249, 1978.
30. Ramakrishnan, S , Fryxell, D , Mohanraj, D., Olson, M., and Li, B-Y. Cytotoxic conjugates containing ribosomal inhibitory proteins. Annu. Rev. Pharmacol. Toxicol., 32: 579-621, 1992.
31. Gitay-Goren, H., Halaban, R., and Neufeld, G Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem. Biophys Res. Commun., 190: 702-708, 1993.
32. Boocock., C. A., Charnock-Jones, D. S., Sharkey, A. M., McLaren, J., Barker, P. J., Wright, K. A , Twentyman, P. R , and Smith, S. K. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J. Natl. Cancer Inst., 87: 506-516, 1995.
33. Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L., Thieme, H., Iwamoto, M., Park, J. E., Nguyen, H., Aiello, L. M., Ferrara, N , and King, G. L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med., 131 1519-1520, 1994.
34. Fava, R. A., Olsen, N J., Spencer-Green, G , Yeo, K. T., Yeo, T K., Berse, B., Jackman, R. W., Senger, D R , Dvorak, H F., and Brown, L F. Vascular permeability factor/vascular growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue J. Exp. Med , 180: 341-346, 1994
35. Kondo, S., Asano, M., Matsuo, K., Ohmori, I., and Suzuki, H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta., 1221: 211-214, 1994
36. Murphy, J. R. Diphtheria-related peptide hormone gene fusions: a molecular genetic approach to chimeric toxin development. Cancer Treat Res., 37: 123-140, 1988
37. Colombatti, M., Greenfield, L., and Youle, R. J Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry. J Biol Chem , 261: 3030-3035, 1986
38. Choe, S , Bennett, M , Fujii, G., Curmi, P. M G., Kantardjieff, K. A., Collier, R J , and Eisenberg, D. The crystal structure of diphtheria toxin. Nature (Lond ), 357. 216-222, 1992.
39. Silverman, J A., Mindell, J. A., Finkelstein, A., Shen, W H., and Collier, R. J. Mutational analysis of the helical hairpin region of diphtheria toxin transmembrane domain. J Biol. Chem., 269: 22524-22532, 1994
40. Madshus, I. H., Wiedlocha, A , and Sandvig, K Intermediates in translocation of diphtheria toxin across the plasma membrane. J Biol Chem., 269: 4648-4652, 1994
41. Fulcher, S., Lui, G , Houston, L L., Ramakrishnan, S , Burris, T., Polansky, J., and Alvarado, J. Use of immunotoxins to inhibit proliferating human corneal endothelium Invest. Opthalmol & Visual Sci., 29: 755-759, 1988.
42. Plate, K. H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res , 53: 5822-5827, 1993.
43. Plate, K H , Breier, G., Weich, H A , Mennel, H. D., and Risau, W Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in viva regulatory mechanisms Int. J. Cancer., 59: 520-529, 1994.